ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 72 filers reported holding ATHIRA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $286,979 | -33.8% | 142,069 | -3.3% | 0.00% | -100.0% |
| Q2 2023 | $433,559 | +26.4% | 146,969 | +7.1% | 0.00% | 0.0% |
| Q1 2023 | $342,923 | -26.1% | 137,169 | -6.4% | 0.00% | 0.0% |
| Q4 2022 | $464,061 | +14.9% | 146,569 | +7.8% | 0.00% | 0.0% |
| Q3 2022 | $404,000 | -1.9% | 136,019 | +0.7% | 0.00% | 0.0% |
| Q2 2022 | $412,000 | -77.3% | 135,019 | +0.4% | 0.00% | -75.0% |
| Q1 2022 | $1,817,000 | +3.2% | 134,519 | -0.4% | 0.00% | +33.3% |
| Q4 2021 | $1,761,000 | +43.5% | 135,119 | +3.2% | 0.00% | 0.0% |
| Q3 2021 | $1,227,000 | -8.5% | 130,894 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $1,341,000 | +380.6% | 130,994 | +762.9% | 0.00% | +200.0% |
| Q1 2021 | $279,000 | -43.4% | 15,180 | +5.6% | 0.00% | 0.0% |
| Q4 2020 | $493,000 | +24550.0% | 14,380 | +14280.0% | 0.00% | – |
| Q3 2020 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |